When Big Pharma Spends, Research Isn’t No. 1

July 14, 2017 – The high costs of their products are justified because the proceeds generate money for crucial research on new cures and treatments. It’s a compelling argument, but only partly true…

READ MORE @ NYTimes.com


Subscribe Today! Your best source of current news, information and opinion about the issues that matter to you most. Serving the treatment industry, recovery community and health and wellness professionals.